Drivers of fine-scale avian functional diversity with changing land use: an assessment of the effects of eco-estate housing development and management

Landscape Ecology - The effects of changing land use, and especially urbanisation, on species and functional diversity are of global concern. Eco-estates are a form of urban housing development...     

Verrucosamide,a Cytotoxic 1,4-Thiazepane-Containing Thiodepsipeptide from a Marine-Derived Actinomycete

A new cytotoxic thiodepsipeptide, verrucosamide (1), was isolated along with the known, related cyclic peptide thiocoraline, from the extract of a marine-derived actinomycete, a Verrucosispora sp., our strain CNX-026. The new peptide, which is composed of two rare seven-membered 1,4-thiazepane rings, was elucidated by a combination of spectral methods and the absolute configuration was determined by a single X-ray diffraction study. Verrucosamide (1) showed moderate cytotoxicity and selectivity in the NCI 60 cell line bioassay. The most susceptible cell lines were MDA-MB-468 breast carcinoma with an LD₅₀ of 1.26 µM, and COLO 205 colon adenocarcinoma with an LD₅₀ of 1.4 µM. Also isolated along with verrucosamide were three small 3-hydroxy(alkoxy)-quinaldic acid derivatives that appear to be products of the same biosynthetic pathway.     

Epidermal growth factor-like activity in mares' milk.

Epidermal growth factor (EGF)-like activity was measured in mares' colostrum and milk by radioreceptor assay. Milk samples were collected from 22 mares 1 or more times during early lactation. Samples of colostrum were taken after parturition and before the foal first suckled (presuckle), within 6 hours after the foal first suckled (postsuckle), and on days 1, 2, 4, and 8 of lactation. In the 5 mares from which milk samples were obtained at each sampling time, presuckle colostral mean EGF-like activity (17.8 ng/ml) was greatest (P less than 0.05). The mean values for EGF-like activity at all other sampling times were not significantly different from each other (postsuckle colostrum, 9.7 ng/ml; day 1, 9.6 ng/ml; day 2, 8.5 ng/ml; day 4, 8.0 ng/ml; day 8, 7.8 ng/ml).     

Clinical response of nasal adenocarcinoma to cisplatin chemotherapy in 11 dogs.

In 11 dogs with nasal adenocarcinoma, IV treatment with 2 to 8 cycles of cisplatin at a dosage of 60 mg/m2 of body surface, given at 3-week intervals, resulted in a survival time of 8 to 128 weeks (mean, 32.7 weeks; median, 20 weeks). Radiography revealed complete remission in 2 dogs and partial remission in 1 dog, for an overall response rate of 27%. Clinical problems such as nasal discharge (n = 11), sneezing (n = 6), and epistaxis (n = 4) resolved in 1 to 2 weeks in all dogs after beginning chemotherapy.     

Study of prostatic disease in dogs: 177 cases (1981-1986).

Historical and physical signs associated with prostatic disease diagnosed in dogs over a 5.5-year period were defined. One hundred seventy-seven male dogs were determined to have prostatic abnormality. Of the 177 dogs, 87 were determined to have specific prostatic disease. The most common prostatic disease identified in this study was bacterial prostatitis, followed by prostatic cyst, prostatic adenocarcinoma, and benign hyperplasia. The most common prostatic disease identified in neutered dogs was prostatic adenocarcinoma. Mean age at onset of prostatic disease was 8.9 years; statistically significant difference was not observed between age at onset of the various types of prostatic disease identified. Doberman Pinscher was the most common breed with prostate disease. Twenty-nine percent of dogs with a specifically identifiable prostatic disease had signs of systemic illness, 41% had signs of lower urinary tract disease, 28% had signs of gastrointestinal tract abnormalities, and 13% had signs of locomotor difficulty.     

Evaluation of the Hennessy grading probe to predict yields of lamb carcasses fabricated to multiple end points.

Lamb carcasses (n = 278) were selected immediately after slaughter and fat thickness was measured with the SP2 Hennessy grading probe (HP) at the interface of the 12th and 13th ribs, 3.8 cm from the backbone. After a 24-h chilling period, carcasses were graded by a USDA grader and probed with the HP to obtain a fat thickness measure on the chilled carcass. One hundred sixty-five carcasses were fabricated into wholesale cuts (.64 cm of external fat trim), and 113 carcasses were fabricated into tray-ready retail cuts (.25 cm of external fat trim). Carcass weight, fat thickness (metal probe), adjusted fat thickness, hot and chilled carcass HP fat measures, as well as kidney and pelvic fat percentage and USDA yield grade, were highly correlated to cutting yield for both fabrication methods. Regression models developed to predict wholesale cut yields using HP or grader-collected measures were similar with respect to predictive accuracy. Fat thickness explained most of the variation in wholesale and tray-ready cut yields among the variables collected by the grader. Kidney and pelvic fat accounted for more of the variation in yield of wholesale cuts during stepwise regression to determine HP equations, but for predicting tray-ready yields, fat thickness taken with the HP accounted for the largest amount of variation. Equations developed to predict tray-ready retail cut yields using the HP or USDA grader-collected carcass measures were similar in the amount of variation explained. Kidney and pelvic fat percentage must be included in equations to maximize predictive accuracy when this depot site is left in carcasses.     

Cryptococcal osteomyelitis in a dog

Osteomyelitis caused by Cryptococcus neoformans was diagnosed in a three-year-old male Irish wolfhound. The case details and radiological findings of radiolucency and periosteal reaction of the left third metatarsal bone had lead to an initial diagnosis of a malignant bone tumour. Biopsy revealed a fungal granuloma and culture identified the causal organism. A four month course of ketaconazole was instigated and the lameness resolved. Twelve months after the end of treatment there was no recurrence of the problem.     

Consistency of results from the Vettest 8008 clinical biochemistry analyser.

Findings are presented on the precision of a clinical biochemistry analyser designed specifically for veterinary use. Twenty biochemical analytes have been examined in detail for variation within and between runs. The results indicate that the analyser can provide high precision for all the analytes with the possible exception of calcium, and suggest that the instrument can be used with confidence in the practice laboratory to aid diagnosis and to monitor biochemical changes in animals receiving treatment.